Dedicated Tracks to MOVE WITH CERTAINTY THROUGH DRUG DEVELOPMENT
Track 1: The Business Impact of Modeling and Biosimulation in Drug Development
Take the holistic view and see how quantitative methods can better inform every decision on the road from discovery to market access. We’ll look at specific processes and indications to go beyond theory and illustrate the practice.
Track 2: End to End Clinical Data Flow Automation
More studies with more data sources in less time. That’s the demand. The need? Building quality and efficiency into every stage of the process. From ADaM to SDTM, we’ll explore the new gold standards in automation and validation.
Track 3: Regulatory Sciences Strategy, Automation & Insights
Ready to file? The package is just important as its contents: all your data. Change is afoot with eCTD v4.0 and the potential of generative AI to assist with regulatory writing. Join this track to stay ahead of the approval curve.